Brind.

Nuera, a biofabrication venture, secures commercial orders from Kering

1 report, 1 independent Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Ayham Hassan selected Lunaform for a design, and Nuera secured commercial orders from Kering. Nuera is a biofabrication venture launched by Desa, a leather manufacturer in Turkey, which uses Lunaform biomaterial and proprietary BioCraft technology to create finished goods. Nuera operates as a wholly owned subsidiary of Desa and holds exclusive global rights to commercialize Lunaform through a long-term licensing agreement with Gozen.

From wwd.com

Why it matters

Some supportBrind's analysis of the reports

The venture represents an integrated effort to bring next-generation biomaterials into commercial production, moving them from lab scale to industrial mass production. This adoption by Kering validates the commercial viability of sustainable alternatives to animal leather, addressing a major industry hurdle noted by Desa chief executive Burak Çelet.

From wwd.com

Who's involved

  • Ayham HassanPalestinian fashion designer who selected Lunaform for a design.
  • KeringFrench business that secured commercial orders from Nuera.
  • DESAParent company of Nuera, the biofabrication venture.

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • KeringSpeculative

    Kering might see changes in supply chain costs or material sourcing as it integrates Nuera's biofabrication material.

  • DESASpeculative

    Desa could see increased revenue and market credibility for its biomaterials venture, Nuera.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped